tiprankstipranks
Trending News
More News >
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
US Market
Advertisement

Elicio Therapeutics (ELTX) Income Statement

Compare
213 Followers

Elicio Therapeutics Income Statement

Last quarter (Q3 2025), Elicio Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Elicio Therapeutics's net income was $-10.08M. See Elicio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 28.31M$ 2.88M
Gross Profit
$ -1.18M$ -1.17M$ -1.06M$ 27.08M$ 1.06M
Operating Expenses
$ 43.81M$ 34.58M$ 22.68M$ 66.39M$ 56.34M
Depreciation and Amortization
$ 1.18M$ 1.17M$ 1.06M$ 801.00K$ 628.00K
EBITDA
$ -50.27M$ -32.97M$ -23.55M$ -51.92M$ -70.63M
Operating Income
$ -44.99M$ -35.74M$ -23.73M$ -39.31M$ -55.27M
Other Income/Expenses
$ -6.91M$ 550.00K$ -4.47M$ -15.27M$ -24.83M
Pretax Income
$ -51.90M$ -35.20M$ -28.21M$ -54.57M$ -80.11M
Net Income
$ -51.90M$ -35.20M$ -28.21M$ -26.40M$ -80.11M
Per Share Metrics
Basic EPS
$ -4.25$ -6.96$ -9.10$ -19.32$ -1.93
Diluted EPS
$ -4.25$ -6.96$ -9.10$ -19.32$ -1.93
Weighted Average Shares Outstanding
12.20M 5.06M 3.10M 3.20M 8.15M
Weighted Average Shares Outstanding (Diluted)
12.20M 5.06M 3.10M 3.20M 8.15M
Currency in USD

Elicio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis